Last update 21 Nov 2024
MG-ZG122
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with MG-ZG122Safety, Tolerability, and Pharmacokinetics of MG-ZG122 in a Single Subcutaneous Injection in Chinese Healthy Adult Subjects: a Single-center, Randomized, Double-blind, Placebo-controlled, Dose-increasing Phase I Clinical Trial
MG-ZG122人源化单抗注射液在中国健康成年志愿者中单次皮下注射给药的安全性、耐受性、药代动力学研究：一项单中心、随机、双盲、安慰剂对照、剂量递增的Ⅰ期临床研究
[Translation] Safety, tolerability, and pharmacokinetics of a single subcutaneous injection of MG-ZG122 humanized monoclonal antibody injection in healthy Chinese adult volunteers: a single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical study
Safety, tolerability, and pharmacokinetic profiles of MG-ZG122 humanized monoclonal antibody injection administered as a single subcutaneous injection in healthy Chinese adult volunteers: a single-center, randomized, double-blind, placebo-controlled, dose-escalating phase I clinical study
100 Clinical Results associated with MG-ZG122
Login to view more data
100 Translational Medicine associated with MG-ZG122
Login to view more data
100 Patents (Medical) associated with MG-ZG122
Login to view more data
100 Deals associated with MG-ZG122
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 1 | CN | 06 Feb 2023 | |
| Pulmonary Disease, Chronic Obstructive | IND Approval | CN | 25 Jul 2022 | |
| Dermatitis, Atopic | IND Approval | CN | 31 May 2022 | |
| Sinusitis | IND Approval | CN | 31 May 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free